ArticleTranslational lung cancer research2020

Compare the efficacy and safety of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) inhibitors for advanced non-small cell lung cancer: a Bayesian analysis.

Jiaqi Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.